HOME PRODUCTS SERVICES COMPANY CONTACT FAQ

Research Dictionary Pharma Mobile

Sign Up FREE or Login

68Ga-DOTANOC

Subscribe to New Research on 68Ga-DOTANOC

a PET imaging compound specific to somatostatin receptors subtypes 2 and 5; no further info available 10/2005

Networked: 24 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Experts

1.	Kumar, Rakesh: 13 articles (12/2014 - 09/2012)
2.	Bal, Chandrasekhar: 12 articles (12/2014 - 09/2012)
3.	Sharma, Punit: 12 articles (12/2014 - 11/2012)
4.	Naswa, Niraj: 7 articles (12/2014 - 09/2012)
5.	Malhotra, Arun: 6 articles (04/2014 - 09/2012)
6.	Dhull, Varun Singh: 6 articles (04/2014 - 06/2013)
7.	Fanti, Stefano: 4 articles (12/2015 - 05/2010)
8.	Allegri, Vincenzo: 4 articles (12/2015 - 05/2010)
9.	Karunanithi, Sellam: 4 articles (06/2013 - 09/2012)
10.	Ambrosini, Valentina: 3 articles (12/2015 - 05/2010)

Related Diseases

1.	Neuroendocrine Tumors (Neuroendocrine Tumor) 12/01/2015 - "Prognostic Value of 68Ga-DOTANOC PET/CT SUVmax in Patients with Neuroendocrine Tumors of the Pancreas." 01/01/2014 - "Predictive value of 68Ga-DOTANOC PET/CT in patients with suspicion of neuroendocrine tumors: is its routine use justified?" 04/01/2012 - "A rare case of synchronous bilateral pulmonary neuroendocrine tumor detected by 68Ga-DOTANOC PET/CT." 05/01/2010 - "68Ga-DOTANOC PET/CT clinical impact in patients with neuroendocrine tumors." 12/01/2014 - "Comparison of the prognostic values of 68Ga-DOTANOC PET/CT and 18F-FDG PET/CT in patients with well-differentiated neuroendocrine tumor."
2.	Neuroendocrine Carcinoma 09/01/2012 - "Metastatic neuroendocrine carcinoma presenting as a "Superscan" on 68Ga-DOTANOC somatostatin receptor PET/CT." 10/01/2013 - "We present a rare case of primary sinonasal neuroendocrine carcinoma in a 61-year-old male patient where somatostatin receptor PET/CT with 68Ga-DOTANOC correctly delineated the extent of primary tumor as compared to contrast-enhanced CT, thereby changing patient management."
3.	Pheochromocytoma 04/01/2014 - "Pheochromocytoma presenting with remote bony recurrence twenty years after initial surgery: detection with 68Ga-DOTANOC PET/CT." 02/01/2011 - "I-123 MIBG scintigraphy and 68Ga-DOTANOC PET/CT negative but F-18 DOPA PET/CT positive pheochromocytoma: a case report."
4.	Paraganglioma (Paragangliomas) 06/01/2013 - "68Ga-DOTANOC PET/CT for baseline evaluation of patients with head and neck paraganglioma." 12/01/2013 - "In our case, somatostatin receptor PET/CT with 68Ga-DOTANOC correctly assessed the extent of the disease in a patient with multifocal paraganglioma."
5.	Neoplasms (Cancer) 08/01/2013 - "Successful localization of residual culprit tumor in a case of tumor-induced osteomalacia using 68Ga-DOTANOC PET/CT." 10/01/2013 - "We present a rare case of primary sinonasal neuroendocrine carcinoma in a 61-year-old male patient where somatostatin receptor PET/CT with 68Ga-DOTANOC correctly delineated the extent of primary tumor as compared to contrast-enhanced CT, thereby changing patient management."

Related Drugs and Biologics

1.	Somatostatin Receptors (Somatostatin Receptor)
2.	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)
3.	68Ga-DOTATATE
4.	3-Iodobenzylguanidine (Iobenguane)
5.	Dihydroxyphenylalanine (Dopa)
6.	Adrenocorticotropic Hormone (ACTH)